Abstract
Astrocytes are important glial cells involved in the ionic regulation of the extracellular fluid in the Central Nervous System (CNS), the formation of the blood brain barrier (BBB) and the support to neurons for the maintenance of the Krebs cycle intermediaries. Even though these cells are known to be important for the brain functioning, several of their functions and their development have not been fully elucidated. In this context, identifying the algorithms used for their analysis plays a pivotal role in the development of new strategies in the study of astrocytes. The main objective of this review is to summarize the techniques that have helped to obtain transcriptomic data in astrocytes and the new algorithms that were used to perform the analysis of experimental data, elucidating new studies in which these had been used. We also highlight the current transcriptomics approaches targeting astrocytes function as a possible target for pharmacological interventions.
Keywords: Astrocytes, transcriptome methods, brain, neurological disorders, central nervous system, blood brain barrier.
Current Pharmaceutical Design
Title:Approaches of the Transcriptomic Analysis in Astrocytes: Potential Pharmacological Targets
Volume: 23 Issue: 28
Author(s): George E. Barreto *, Rosa M. Gomez, Rosa Helena Bustos, Diego A. Forero, Gjumrakch Aliev, Vadim V. Tarasov, Nagendra S. Yarla, Valentina Echeverria and Janneth Gonzalez
Affiliation:
- Departamento de Nutricion y Bioquimica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogota D.C,Colombia
Keywords: Astrocytes, transcriptome methods, brain, neurological disorders, central nervous system, blood brain barrier.
Abstract: Astrocytes are important glial cells involved in the ionic regulation of the extracellular fluid in the Central Nervous System (CNS), the formation of the blood brain barrier (BBB) and the support to neurons for the maintenance of the Krebs cycle intermediaries. Even though these cells are known to be important for the brain functioning, several of their functions and their development have not been fully elucidated. In this context, identifying the algorithms used for their analysis plays a pivotal role in the development of new strategies in the study of astrocytes. The main objective of this review is to summarize the techniques that have helped to obtain transcriptomic data in astrocytes and the new algorithms that were used to perform the analysis of experimental data, elucidating new studies in which these had been used. We also highlight the current transcriptomics approaches targeting astrocytes function as a possible target for pharmacological interventions.
Export Options
About this article
Cite this article as:
Barreto E. George *, Gomez M. Rosa, Bustos Helena Rosa , Forero A. Diego , Aliev Gjumrakch , Tarasov V. Vadim , Yarla S. Nagendra , Echeverria Valentina and Gonzalez Janneth , Approaches of the Transcriptomic Analysis in Astrocytes: Potential Pharmacological Targets, Current Pharmaceutical Design 2017; 23 (28) . https://dx.doi.org/10.2174/1381612823666170406113501
DOI https://dx.doi.org/10.2174/1381612823666170406113501 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting Opioid and Neurokinin-1 Receptors to Treat Alcoholism
Current Medicinal Chemistry Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Nanoparticles in the Pharmaceutical Industry and the Use of Supercritical Fluid Technologies for Nanoparticle Production
Current Drug Delivery Combination of P300 and CSF β-Amyloid(1-42) Assays May Provide a Potential Tool in the Early Diagnosis of Alzheimers Disease
Current Alzheimer Research Cytokines as a Precipitant of Depressive Illness: Animal and Human Studies
Current Pharmaceutical Design Editorial: Astrocyte-Targeted Therapeutic Strategies for Neurological Disorders
Current Pharmaceutical Design What Western Pharmacists Need to Know About Traditional Chinese Medicine; A Canadian Perspective
Current Traditional Medicine Functional Interference of Dexamethasone on Some Morphine Effects:Hypothesis for the Steroid-Opioid Interaction
Recent Patents on CNS Drug Discovery (Discontinued) Role of Physician Gender in the Quality of Care of Cardiometabolic Diseases
Current Pharmaceutical Design Angiogenesis and Hypoxia in Glioblastoma: A Focus on Cancer Stem Cells
CNS & Neurological Disorders - Drug Targets Alginate Based Nanocarriers for Drug Delivery Applications
Current Pharmaceutical Design The Search for γ-Secretase and Development of Inhibitors
Current Medicinal Chemistry Strict Adherence to Guidelines in Decision Making for Coronary Angiography in Patients Who have Survived a Q Wave Myocardial Infarction; 2-Year Outcome in a Greek Population
Vascular Disease Prevention (Discontinued) Mitogen Activated Protein (MAP) Kinases: Development of ATP and Non- ATP Dependent Inhibitors
Medicinal Chemistry Editorial [‘Current Alzheimer Research’ Helps Accelerate the Progress of the Field]
Current Alzheimer Research Methods for Mining Single Nucleotide Polymorphism Data of Complex Diseases
Current Bioinformatics Oral Immune Regulation: A New Mode of Therapy Against Chronic Viral Infections
Recent Patents on Anti-Infective Drug Discovery Emotion and Destination Memory in Alzheimer’s Disease
Current Alzheimer Research Gene Therapy in the Management of Parkinson’s Disease: Potential of GDNF as a Promising Therapeutic Strategy
Current Gene Therapy New Strategies for Clinical Trials in Autism Spectrum Disorder
Reviews on Recent Clinical Trials